top of page
%20(1).png)
A new approach to
cardiac regeneration
Amnova Biotech is developing a localized injectable therapy designed to restore cardiac function after myocardial infarction.
Delivered directly into the damaged myocardium, our technology enables controlled and targeted release of regenerative signals, activating the body’s own repair mechanisms.
By addressing the underlying loss of functional cardiac tissue, our approach aims to reduce scar formation, preserve cardiac function, and improve patient outcomes.
Key advantages
Localized
delivery
Direct administration into the site of injury for targeted effect.
Cell-free therapy
Avoids the complexity and limitations of cell-based approaches.
Off-the-shelf solution
Ready-to-use, enabling stability and clinical integration.
Biomaterial platform
Designed for controlled delivery of therapeutic signals.
bottom of page